C4 Therapeutics, Inc.CCCCNASDAQ
LOADING
|||
R&D Expense Growth Under Pressure
Trending lower, below historical average.
Left:
||||
Year-over-year research & development expense growth
Latest
-6.01%
↓ 125% below average
Average (6y)
24.34%
Historical baseline
Range
High:68.09%
Low:-6.01%
Volatility
304.5%
High variability
| Period | Value |
|---|---|
| 2024 | -6.01% |
| 2023 | -0.11% |
| 2022 | 24.48% |
| 2021 | 20.68% |
| 2020 | 63.22% |
| 2019 | 68.09% |
| 2018 | 0.00% |